Epilepsy with Myoclonic-Atonic Seizures Treatments
Find Epilepsy with Myoclonic-Atonic Seizures Treatments
Brand Name
Diacomit
Generic Name
Stiripentol
View Brand Information FDA approval date: August 21, 2018
Form: Powder, Capsule
What is Diacomit (Stiripentol)?
DIACOMIT is indicated for the treatment of seizures associated with Dravet syndrome in patients taking clobazam who are 6 months of age and older and weighing 7 kg or more. There are no clinical data to support the use of DIACOMIT as monotherapy in Dravet syndrome. DIACOMIT is indicated for the treatment of seizures associated with Dravet syndrome in patients taking clobazam who are 6 months of age and older and weighing 7 kg or more. There are no clinical data to support the use of DIACOMIT as monotherapy in Dravet syndrome.
Save this treatment for later
Not sure about your diagnosis?
Tired of the same old research?
Related Clinical Trials
There is no clinical trials being done for this treatment